E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board in a pivotal step in the company's ongoing growth strategy. Jean-Charles Wirth will ...

Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...

Summary: The Board erred by failing to explain why it discarded material and unrebutted evidence that a reference constitutes prior art.

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

German pharma company Merck has unveiled its CEO-designate, along with a new corporate image. Stefan Oschmann has been named as the new chairman of the executive board and CEO of Merck KGaA ...

The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...

Yesterday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision vacating the Patent Trial and Appeal Board’s determination that CQV failed to show the unpatentability of ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous challenges plaguing the company resulted in the dilution of the stock ...

As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a cash sweetener. Monday, Delaware’s state investment board approved a $ ...